Precipio, Inc. (NASDAQ:PRPO) Sees Large Drop in Short Interest

Precipio, Inc. (NASDAQ:PRPO) was the target of a significant decrease in short interest in June. As of June 15th, there was short interest totalling 1,200 shares, a decrease of 14.3% from the May 31st total of 1,400 shares. Based on an average daily volume of 4,200 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.1% of the shares of the company are short sold.

Precipio Stock Performance

PRPO opened at $5.38 on Tuesday. The company has a current ratio of 0.78, a quick ratio of 0.62 and a debt-to-equity ratio of 0.01. The firm’s fifty day moving average price is $5.74 and its two-hundred day moving average price is $6.13. Precipio has a fifty-two week low of $4.65 and a fifty-two week high of $8.99.

Precipio (NASDAQ:PRPO) last released its quarterly earnings data on Tuesday, May 14th. The biotechnology company reported ($1.46) EPS for the quarter. Precipio had a negative return on equity of 46.12% and a negative net margin of 31.00%. The business had revenue of $3.43 million for the quarter.

About Precipio

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.